227 related articles for article (PubMed ID: 1702326)
21. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
22. Lack of CD24 antigen expression in B-lineage acute lymphoblastic leukemia is associated with intrinsic radiation resistance of primary clonogenic blasts.
Uckun FM; Song CW
Blood; 1993 Mar; 81(5):1323-32. PubMed ID: 8443393
[TBL] [Abstract][Full Text] [Related]
23. Increased inhibition of proliferation of human B cell lymphomas following ligation of CD40, and either CD19, CD20, CD95 or surface immunoglobulin.
Benoit NE; Wade WF
Immunopharmacology; 1996 Nov; 35(2):129-39. PubMed ID: 8956976
[TBL] [Abstract][Full Text] [Related]
24. The CD24 antigen discriminates between pre-B and B cells in human bone marrow.
Duperray C; Boiron JM; Boucheix C; Cantaloube JF; Lavabre-Bertrand T; Attal M; Brochier J; Maraninchi D; Bataille R; Klein B
J Immunol; 1990 Dec; 145(11):3678-83. PubMed ID: 1700990
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory coreceptors activated by antigens but not by anti-Ig heavy chain antibodies install requirement of costimulation through CD40 for survival and proliferation of B cells.
Hokazono Y; Adachi T; Wabl M; Tada N; Amagasa T; Tsubata T
J Immunol; 2003 Aug; 171(4):1835-43. PubMed ID: 12902484
[TBL] [Abstract][Full Text] [Related]
26. Cross-linking CD40 on human B cell precursors inhibits or enhances growth depending on the stage of development and the IL costimulus.
Larson AW; LeBien TW
J Immunol; 1994 Jul; 153(2):584-94. PubMed ID: 7517420
[TBL] [Abstract][Full Text] [Related]
27. Immunophenotypic differences between putative hematopoietic stem cells and childhood B-cell precursor acute lymphoblastic leukemia cells.
Lamkin T; Brooks J; Annett G; Roberts W; Weinberg K
Leukemia; 1994 Nov; 8(11):1871-8. PubMed ID: 7526089
[TBL] [Abstract][Full Text] [Related]
28. Differences in IgE isotype switching induced by anti-CD40 monoclonal antibody and cytokines among subtypes of chronic B lymphoid leukemias.
Takeuchi H; Kayano H; Hirose T
Exp Hematol; 2000 May; 28(5):543-50. PubMed ID: 10812244
[TBL] [Abstract][Full Text] [Related]
29. Analysis of expression and function of CD40 on normal and leukemic human B cell precursors.
Law CL; Wörmann B; LeBien TW
Leukemia; 1990 Nov; 4(11):732-8. PubMed ID: 1700237
[TBL] [Abstract][Full Text] [Related]
30. Concomitant delineation of surface Ig, B-cell differentiation antigens, and HLADR on lymphoid proliferations using three-color immunocytometry.
Segal GH; Edinger MG; Owen M; McNealis M; Lopez P; Perkins A; Linden MD; Fishleder AJ; Stoler MH; Tubbs RR
Cytometry; 1991; 12(4):350-9. PubMed ID: 1712263
[TBL] [Abstract][Full Text] [Related]
31. Expression of the CEA gene family members NCA-50/90 and NCA-160 (CD66) in childhood acute lymphoblastic leukemias (ALLs) and in cell lines of B-cell origin.
Hanenberg H; Baumann M; Quentin I; Nagel G; Grosse-Wilde H; von Kleist S; Göbel U; Burdach S; Grunert F
Leukemia; 1994 Dec; 8(12):2127-33. PubMed ID: 7808000
[TBL] [Abstract][Full Text] [Related]
32. In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against BCL-1 murine B-cell leukemia.
Uckun FM; Chelstrom LM; Irvin JD; Finnegan D; Gunther R; Young J; Kuebelbeck V; Myers DE; Houston LL
Blood; 1992 May; 79(10):2649-61. PubMed ID: 1375109
[TBL] [Abstract][Full Text] [Related]
33. B-lineage colonies from normal, human bone marrow are initiated by B cells and their progenitors.
McGinnes K; Letarte M; Paige CJ
Blood; 1991 Mar; 77(5):961-70. PubMed ID: 1704806
[TBL] [Abstract][Full Text] [Related]
34. Expression of CD34 on human B cell precursors.
Schmitt C; Eaves CJ; Lansdorp PM
Clin Exp Immunol; 1991 Jul; 85(1):168-73. PubMed ID: 1712682
[TBL] [Abstract][Full Text] [Related]
35. Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines.
Gruss HJ; DaSilva N; Hu ZB; Uphoff CC; Goodwin RG; Drexler HG
Leukemia; 1994 Dec; 8(12):2083-94. PubMed ID: 7528856
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of four CD22 antibodies as ricin A chain-containing immunotoxins for the in vivo therapy of human B-cell leukemias and lymphomas.
Shen GL; Li JL; Ghetie MA; Ghetie V; May RD; Till M; Brown AN; Relf M; Knowles P; Uhr JW
Int J Cancer; 1988 Nov; 42(5):792-7. PubMed ID: 3263328
[TBL] [Abstract][Full Text] [Related]
37. Immunophenotypic and genotypic analysis of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Correlation with histologic features in 36 cases. French Study Group of Pathology for HIV-Associated Tumors.
Raphael MM; Audouin J; Lamine M; Delecluse HJ; Vuillaume M; Lenoir GM; Gisselbrecht C; Lennert K; Diebold J
Am J Clin Pathol; 1994 Jun; 101(6):773-82. PubMed ID: 8209868
[TBL] [Abstract][Full Text] [Related]
38. Human granulocyte-macrophage colony-stimulating factor supports the clonogenic growth of B-lineage acute lymphoblastic leukemias expressing myeloid antigens.
Gattei V; Aldinucci D; Attadia V; Degan M; Alosi MS; De Iuliis A; Babare R; Rossi FM; Rupolo M; Zagonel V; Pinto A
Cytokines Cell Mol Ther; 1997 Sep; 3(3):141-51. PubMed ID: 9426972
[TBL] [Abstract][Full Text] [Related]
39. CD5 antigen-positive B lymphocytes in human B cell ontogeny during fetal development and after autologous bone marrow transplantation.
Waddick KG; Uckun FM
Exp Hematol; 1993 Jun; 21(6):791-8. PubMed ID: 7684704
[TBL] [Abstract][Full Text] [Related]
40. Variable rate of detection of immunoglobulin heavy chain V-D-J rearrangement by PCR: a systematic study of 41 B-cell non-Hodgkin's lymphomas and leukemias.
Ben-Ezra J
Leuk Lymphoma; 1992 Jul; 7(4):289-95. PubMed ID: 1493428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
